BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3791354)

  • 1. Antiarrhythmic and haemodynamic effects of tiapamil, a new calcium antagonist, during coronary artery occlusion and reperfusion in dogs.
    Shargorodsky BM; Braun S; Belhassen B; Laniado S
    Cardiovasc Res; 1986 Sep; 20(9):652-7. PubMed ID: 3791354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of tiapamil against ventricular fibrillation during coronary artery occlusion.
    Raeder EA; Verrier RL; Lown B
    Am Heart J; 1986 May; 111(5):878-82. PubMed ID: 3706107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil and tiapamil in prevention of ventricular fibrillation in pigs with coronary ligation. Comparative effects on left ventricular function.
    Muller CA; Opie LH; Hamm CW; Peisach M; Pineda CA; Thandroyen FT
    Circulation; 1988 Jul; 78(1):227-32. PubMed ID: 3383406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tiapamil on myocardial performance in coronary artery disease.
    Braun S; Miller H; Terdiman R; Laniado S
    Cardiology; 1982; 69 Suppl():79-84. PubMed ID: 7151086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effects of tiapamil on exercise-induced arrhythmias in patients with coronary artery disease.
    Burkart F; Baitsch G; Braun S; Bertel O; Cocco G
    Cardiology; 1982; 69 Suppl():165-71. PubMed ID: 6758932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker.
    Gerold M; Eigenmann R; Haeusler G
    J Cardiovasc Pharmacol; 1982; 4(3):419-29. PubMed ID: 6177938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effect of the calcium antagonist tiapamil (Ro 11-1781) by intravenous administration in patients with coronary heart disease.
    Nowak FG; Cocco G; Chu D; Gasser DF
    Clin Cardiol; 1980 Dec; 3(6):371-6. PubMed ID: 6161729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tiapamil and nifedepine during critical coronary stenosis and in the presence of adrenergic beta-receptor blockade in anesthetized dogs.
    Saini RK; Fulmor IE; Antonaccio MJ
    J Cardiovasc Pharmacol; 1982; 4(5):770-6. PubMed ID: 6182408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute antianginal effect of tiapamil.
    Gasic S
    Cardiology; 1982; 69 Suppl():209-24. PubMed ID: 6758933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiapamil in the treatment of lidocaine-resistant ventricular arrhythmias complicating acute myocardial infarction.
    Lessem J
    Cardiology; 1982; 69 Suppl():199-208. PubMed ID: 7151080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiapamil--a new calcium antagonist.
    Opie LH; Muller CA; Thandroyen FT; Lloyd EA; Mabin T; Commerford PJ; Eichler HG
    S Afr Med J; 1985 Jun; 67(22):881-3. PubMed ID: 3890216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cardiac arrhythmias with tiapamil.
    Brisse B; Bender F; Bramann H; Kuhs H; Schwippe G
    Cardiology; 1982; 69 Suppl():144-8. PubMed ID: 7151076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiapamil, a new calcium antagonist: hemodynamic effects in patients with acute myocardial infarction.
    Eichler HG; Mabin TA; Commerford PJ; Lloyd EA; Beck W; Opie LH
    Circulation; 1985 Apr; 71(4):779-86. PubMed ID: 3882269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection by the calcium antagonist tiapamil, against cardiac lymphatic enzyme leakage and arrhythmias in canine hearts during reperfusion.
    Matsuura A; Ishihara T; Nakamura K; Himori N; Nakamura K
    J Cardiovasc Pharmacol; 1986; 8(1):90-8. PubMed ID: 2419700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemodynamic effects of intravenous tiapamil in patients with coronary artery disease.
    Bopp P; Mérier G; Scheidegger D; Gabathuler J; Rutishauser W
    Cardiology; 1982; 69 Suppl():91-8. PubMed ID: 7151088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs.
    Saini RK; Fulmor IE; Parham CS; Antonaccio MJ
    J Pharmacol Exp Ther; 1986 Apr; 237(1):1-8. PubMed ID: 3958960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral tiapamil treatment of arrhythmias in cardiac patients.
    Menzel T; Kirchner P
    Cardiology; 1982; 69 Suppl():192-8. PubMed ID: 6185224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic effect of tiapamil in patients with acute myocardial infarction.
    Dubner S; Gimeno G; Elencwajg B; Quinteiro R; Tronge J; Bertolasi C
    Cardiology; 1982; 69 Suppl():172-80. PubMed ID: 7151078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs.
    Saini RK; Antonaccio MJ
    J Pharmacol Exp Ther; 1982 Apr; 221(1):29-36. PubMed ID: 7062289
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic effects of tiapamil and verapamil in conscious rats following chronic myocardial infarction.
    Clozel JP
    Cardiology; 1988; 75(3):161-9. PubMed ID: 3416326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.